These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28423734)

  • 1. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.
    Lin HY; Zeng D; Liang YK; Wei XL; Chen CF
    Oncotarget; 2017 May; 8(21):34750-34761. PubMed ID: 28423734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment.
    Wu H; Huang Z; Huang M; Dang Y; Lu H; Qin X; Liang L; Yang L; Ma J; Chen G; Lv Z
    Cell Cycle; 2020 Nov; 19(21):2866-2885. PubMed ID: 33044891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Wu Y; Chen F; Pan L; Chao X; Li M; Luo R; Chen K; Zheng C; Du T; He J; Sun P
    Pathology; 2024 Jun; 56(4):516-527. PubMed ID: 38570266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer.
    Zhou Q; Yang HJ; Zuo MZ; Tao YL
    J Ovarian Res; 2022 Apr; 15(1):49. PubMed ID: 35488350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin.
    Du T; Pan L; Zheng C; Chen K; Yang Y; Chen J; Chao X; Li M; Lu J; Luo R; Zhang J; Wu Y; He J; Jiang D; Sun P
    Breast Cancer Res; 2022 Oct; 24(1):70. PubMed ID: 36284362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Roles of trichorhinophalangeal syndrome-1 gene in normal breast development and breast cancer].
    Bao Y; Zhong ZX; Cui G; Guo L; Wang ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):121-4. PubMed ID: 23469802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
    Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics.
    Yu S; Jiang X; Li J; Li C; Guo M; Ye F; Zhang M; Jiao Y; Guo B
    Sci Rep; 2019 Mar; 9(1):4467. PubMed ID: 30872657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.
    Abba MC; Nunez MI; Colussi AG; Croce MV; Segal-Eiras A; Aldaz CM
    Breast Cancer Res; 2006; 8(6):R64. PubMed ID: 17078870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in Malignancies.
    Feng G; Guo K; Yan Q; Ye Y; Shen M; Ruan S; Qiu S
    Med Sci Monit; 2019 May; 25():3374-3389. PubMed ID: 31063460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
    Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
    Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
    Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.
    Liu J; Prager-van der Smissen WJ; Look MP; Sieuwerts AM; Smid M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
    Cancer Lett; 2016 Jun; 376(1):104-9. PubMed ID: 27018307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells.
    Bouchard MF; Taniguchi H; Viger RS
    Endocrinology; 2005 Nov; 146(11):4905-16. PubMed ID: 16109788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
    Ai D; Yao J; Yang F; Huo L; Chen H; Lu W; Soto LMS; Jiang M; Raso MG; Wang S; Bell D; Liu J; Wang H; Tan D; Torres-Cabala C; Gan Q; Wu Y; Albarracin C; Hung MC; Meric-Bernstam F; Wistuba II; Prieto VG; Sahin AA; Ding Q
    Mod Pathol; 2021 Apr; 34(4):710-719. PubMed ID: 33011748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.
    Zhou XL; Zeng D; Ye YH; Sun SM; Lu XF; Liang WQ; Chen CF; Lin HY
    Oncol Rep; 2018 Oct; 40(4):1897-1906. PubMed ID: 30066902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
    Wu HT; Liu J; Li GW; Shen JX; Huang YT
    Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative expression of TRPS1, GATA3, SOX10, mammaglobin, and GCDFP-15 in effusion specimens with breast carcinoma.
    Bradt A; Jing X; Smola BS; Lew M
    Diagn Cytopathol; 2023 Nov; 51(11):665-673. PubMed ID: 37461248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
    Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S
    Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.